In line with this clinical observation, suppression of FABP4 using a chemical inhibitor (BMS309403) led to decreased TNF-α and IL-6 levels, ameliorating glucose metabolism, and insulin tolerance in the GDM mouse model [36]. This evidence concerns the gene IL6 and gestational diabetes.